Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald C Goff

Showing results (11-20 of 207) with videos related to

Pageof 21
Sort By:
JAMA|December 28, 2020
The Pharmacologic Treatment of Schizophrenia-2021Donald C Goff
JAMA|May 22, 2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with newDonald C Goff
The Journal of Clinical Psychiatry|August 19, 2007
Integrating general health care in private community psychiatry practiceDonald C Goff
Current Neuropharmacology|February 27, 2016
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing PlasticityDonald C Goff
Evidence-Based Mental Health|October 27, 2009
Review: lamotrigine may be an effective treatment for clozapine resistant schizophreniaDonald C Goff
Harvard Review of Psychiatry|December 24, 2005
Pharmacologic implications of neurobiological models of schizophreniaDonald C Goff
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 6, 2013
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophreniaDonald C Goff
JAMA Psychiatry|February 21, 2019
Can Adjunctive Pharmacotherapy Reduce Hospitalization in Schizophrenia?: Insights From Administrative DatabasesDonald C Goff
Journal of Clinical Psychopharmacology|August 12, 2025
Reply to "Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia"Donald C Goff
Schizophrenia Research|May 12, 2005
Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication statusDost Ongür, Donald C Goff
Pageof 21

Showing results (11-20 of 207) with videos related to

Sort By:
Pageof 21
JAMA|December 28, 2020
The Pharmacologic Treatment of Schizophrenia-2021Donald C Goff
JAMA|May 22, 2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with newDonald C Goff
The Journal of Clinical Psychiatry|August 19, 2007
Integrating general health care in private community psychiatry practiceDonald C Goff
Current Neuropharmacology|February 27, 2016
D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing PlasticityDonald C Goff
Evidence-Based Mental Health|October 27, 2009
Review: lamotrigine may be an effective treatment for clozapine resistant schizophreniaDonald C Goff
Harvard Review of Psychiatry|December 24, 2005
Pharmacologic implications of neurobiological models of schizophreniaDonald C Goff
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 6, 2013
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophreniaDonald C Goff
JAMA Psychiatry|February 21, 2019
Can Adjunctive Pharmacotherapy Reduce Hospitalization in Schizophrenia?: Insights From Administrative DatabasesDonald C Goff
Journal of Clinical Psychopharmacology|August 12, 2025
Reply to "Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia"Donald C Goff
Schizophrenia Research|May 12, 2005
Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication statusDost Ongür, Donald C Goff
Pageof 21